A carregar...
6‐Hydroxydopamine lesion and levodopa treatment modify the effect of buspirone in the substantia nigra pars reticulata
BACKGROUND AND PURPOSE: l‐DOPA‐induced dyskinesia (LID) is considered a major complication in the treatment of Parkinson's disease (PD). Buspirone (5‐HT(1A) partial agonist) have shown promising results in the treatment of PD and LID, however no 5‐HT‐based treatment has been approved in PD. The...
Na minha lista:
| Publicado no: | Br J Pharmacol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7429490/ https://ncbi.nlm.nih.gov/pubmed/32464686 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.15145 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|